Cigarette smoking and abstinence: Comparative effects upon cognitive task performance and mood state over 24 hours

Human Psychopharmacology

Volumn 11, Issue 5, 1996, Pages 391-400

  Parrott, A C ^a   Garnham, N J ^a   Wesnes, K ^b   Pincock, C ^b  

^a UNIVERSITY OF EAST LONDON   (United Kingdom)

^b Cognitive Drug Research ^*  (United Kingdom)

Author keywords

abstinence; attention; cognition; irritabilit y; mood; nicotine; performance; smoking; stress; tobacco; withdrawal

Indexed keywords

ABSTINENCE; ADULT; ARTICLE; CIGARETTE SMOKING; COGNITION; CONCENTRATION LOSS; DEPRESSION; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; IRRITABILITY; MALE; MOOD; NORMAL HUMAN; PRIORITY JOURNAL; SMOKING; STRESS; TIME;

EID: 0029904644     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199609)11:5<391::AID-HUP780>3.0.CO;2-Z     Document Type: Article

References (33)

1. Benowitz, N. L. (1990). Pharmacokinetic considerations in understanding nicotine dependence. In: The Biology of Nicotine Dependence, Ciba Foundation Report, 152. Wiley, Chichester.
2. Folkard, S. (1983). Diurnal variation. In: Stress and Fatigue in Human Performance, Hockey, R. (ed.), Wiley, Chichester, pp. 245-272.
3. Foulds, J. (1994). Detrimental effects of nicotine on mood? Addiction, 89, 136-137.
4. Hasenfrantz, M., Michel, C., Nil, R. and Battig, K. (1989). Can smoking increase attention in rapid visual processing during noise? Electrocortical, physiological and behavioural effects. Psychopharmacology, 98, 75-80.
5. Hughes, J. R. (1992). Tobacco withdrawal in self-quitters. Journal of Consulting and Clinical Psychology, 60, 689-697.
6. Hughes, J. R., Higgins, S. T. and Hatsukami D. (1990). Effects of abstinence from tobacco. In: Research Advances in Alcohol and Drug Problems, Vol. 10, Kowslowski, L. T., Annis, H. M., et al. (Eds), Plenum, New York, pp. 317-398.
7. Keenan, R. M., Hatsukami, D. K. and Anton, D. J. (1989). The effects of short-term tobacco deprivation on performance. Psychopharmacology, 98, 126-130.
8. Matthews, G., Jones, D. M. and Chamberlain, A. G. (1990). Refining the measurement of mood: the UWIST mood adjective checklist. British Journal of Psychology, 81, 17-42.
9. Parrott, A. C. (1994). Individual differences in stress and arousal during cigarette smoking. Psychopharmacology, 115, 389-396.
10. Parrott, A. C. (1995a). Stress modulation over the day in cigarette smokers. Addiction, 90, 233-244.
11. Parrott, A. C. (1995b). Smoking cessation leads to reduced stress, but why? International Journal of the Addictions, 30, 1509-1516.
12. Parrott, A. C. and Craig, D. (1992). Cigarette smoking and nicotine gum (0, 2, and 4 mg): effects upon four visual attention tasks. Neuropsychobiology, 25, 34-43.
13. Parrott, A. C. and Garnham, N. J. Mood and cognitive task performance profiles of cigarette smokers, deprived smokers, and nonsmokers. Unpublished.
14. Parrott, A. C. and Roberts, G. (1991). Smoking deprivation and cigarette reinstatement: effects upon visual attention. Journal of Psychopharmacology, 5, 402-407.
15. Parrott, A. C. and Winder, G. (1989). Nicotine chewing gum (2 mg, 4 mg) and cigarette smoking: comparative effects upon vigilance and heart rate. Psychopharmacology, 97, 257-261.
16. Perkins, K. A., Grobe, J. E., Fonte, C. and Breus, M. (1992). Paradoxical effects of smoking on subjective stress versus cardiovascular arousal in males and females. Pharmacology Biochemistry and Behavior, 42, 301-311.
17. Revell, A. (1988). Smoking and performance: a puff-by-puff analysis. Psychopharmacology, 96, 563-565.
18. Russell, M. A. H. (1989). Subjective and behavioural effects of nicotine in humans: some sources of individual variation. Progress in Brain Research, 79, 289-302.
19. Schneider, N. G. and Jarvik, M. E. (1984). Time course of smoking withdrawal symptoms as a function of nicotine replacement. Psychopharmacology, 82, 143-144.
20. Shiffman, S. and Jarvik, M. (1976). Smoking nicotine withdrawal symptoms in two weeks of abstinence. Psychopharmacology, 50, 35-39.
21. Snyder, F. R., Davis, F. C. and Henningfield, J. E. (1989). The tobacco withdrawal syndrome: performance decrements assessed on a computerised test battery. Drug and Alcohol Dependence, 23, 259-266.
22. Stitzer, M. and Gross, J. (1988). Smoking relapse: the role of pharmacological and behavioural factors. In: Nicotine Replacement: A Critical Evaluation, Pomerleau, O.F. and Pomerleau, C. S. (Eds), Liss, New York, pp. 163-184.
23. Surgeon General (1988). The Health Consequences of Smoking: Nicotine Addiction. US Government Printing Office, Washington DC, USA.
24. Thayer, R. E. (1989). The Biopsychology of Mood and Arousal. Oxford University Press, Oxford.
25. Warburton, D. M. (1992). Smoking within reason. Journal of Smoking-Related Disorders, 3, 55-59.
26. Wesnes, K. and Parrott, A. C. (1992). Smoking, nicotine and human performance. In: Handbook of Human Performance, Vol. 2, Smith, A. and Jones, D. M. (Eds), Academic Press, London, pp. 127-167.
27. Wesnes, K. and Warburton, D. M. (1983). Smoking, nicotine and human performance. Pharmacology and Therapeutics, 21, 189-208.
28. Wesnes, K., Simpson, P. M. and Kidd, A. G. (1988). An investigation of the range of cognitive impairments induced by scopolamine 0-6 mg. Human Psychopharmacology, 3, 27-43.
29. West, R., Hajek, P. and Belcher, M. (1989). Time course of cigarette withdrawal symptoms while using nicotine gum. Psychopharmacology, 99, 143-145.
30. West, R. and Russell, M. A. H. (1985). Pre-abstinence smoke intake and smoking motivation as predictors of severity of cigarette withdrawal symptoms. Psychopharmacology, 83, 334-336.
31. West, R. and Russell, M. A. H. (1988). Loss of acute nicotine tolerance and severity of cigarette withdrawal. Psychopharmacology, 94, 563-565.
32. Williams, G. D. (1980). Effect of cigarette smoking on immediate memory and performance. British Journal of Psychology, 71, 83-90.
33. Van Harten, J., Sevens, L., Raghoebar, M., Holland, R., Wesnes, K. and Cournot, A. (1992). Fluoxamine does not interact with alcohol nor potentiate alcohol-related impairment of cognitive function. Clinical Pharmacology and Therapeutics, 52, 427-435.